Pillsbury Winthrop Shaw Pittman LLP advised NEUCA Group on the deal while Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical. NEUCA Group, the parent...
NEUCA’s Partnership with OncoBay
Scipher Medicine’s Acquisition of CrossBridge
Ropes & Gray represented Scipher Medicine on the deal. Precision immunology company Scipher Medicine announced its acquisition of data, analytics and software company CrossBridge to enhance...
Clinscience’s Investment in OncoBay
Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical on the deal. OncoBay obtained an investment from Clinscience, a global clinical research organization based in Warsaw,...
Cambrex’s Acquisition of Snapdragon Chemistry
Ropes & Gray advised Cambrex on the deal. Cambrex, a global contract development manufacturing organization (CDMO) providing products and services across the entire drug lifecycle, signed a...
TSG Consumer Partners and Oak Hill Capital’s Minority Investment in The Wrench Group
Ropes & Gray advised TSG Consumer Partners and Oak Hill Capital in the transaction. TSG Consumer Partners and Oak Hill Capital announced a significant minority investment...
Intrinsic Medicine’s Business Combination Agreement with Phoenix Biotech Acquisition Corp.
Ropes & Gray advised Intrinsic, while Goodwin Procter advised PBAX on the deal. Intrinsic Medicine, Inc., a therapeutics company leveraging human milk biology to transform Gut-Brain...
Virtus Investment’s Acquisition of AlphaSimplex
Morgan Lewis & Bockius advised Virtus on the transaction, while Ropes & Gray advised Natixis Investment Managers. Natixis Investment Managers announced its sale of AlphaSimplex, a...
Ginkgo Bioworks and Bayer’s Collaboration to Build Agricultural Biologicals R&D Platform
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
Berkshire Partners’ Acquisition of Majority Stake in AHEAD
Ropes & Gray advised Berkshire Partners in the transaction, while Kirkland & Ellis represented AHEAD and Centerbridge. Berkshire Partners executed its acquisition of a majority stake...
Ginkgo Bioworks’ $83 Million Collaboration With Bayer
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, signed an agreement with Bayer to expand Ginkgo’s platform capabilities...
Ginkgo Bioworks’ Acquisition of Zymergen Inc.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
Patient Square Capital and Gurnet Point Capital’s $890 Million Acquisition of Radius Health
Kirkland & Ellis advised Patient Square Capital, Ropes & Gray advised Radius, Latham & Watkins advised Gurnet Point Capital, Covington & Burling served as OrbiMed’s legal...